Related Experiment Video

Updated: May 22, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

Implications of therapy-induced selective autophagy on tumor metabolism and survival

Luke R K Hughson1, Vincent I Poon, Jaeline E Spowart

  • 1Deeley Research Centre, BC Cancer Agency, 2410 Lee Avenue, Victoria, BC, Canada V8R 6V5.

International Journal of Cell Biology
|May 3, 2012
PubMed

Insights

Cancer therapies activating selective autophagy pathways can be enhanced by targeting metabolic reprogramming. Disrupting these metabolic changes offers a promising strategy to improve treatment efficacy in various cancers.

Area of Science:

  • Cellular Biology
  • Cancer Research
  • Metabolism

Background:

  • Cancer therapies inducing apoptosis trigger selective autophagy, involving mitophagy, nucleophagy, and ubiquitin-mediated autophagy.
  • Selective autophagy counteracts therapy-induced damage and reprograms cellular metabolism to manage stress.

Purpose of the Study:

  • To explore how anticancer treatments activate selective autophagy and influence cellular metabolism.
  • To identify opportunities for targeting metabolic irregularities induced by selective autophagy to enhance cancer therapy.

Main Methods:

  • Review of accumulating evidence on cancer therapy-induced apoptosis and selective autophagy.
  • Analysis of the role of selective autophagy in cellular energy metabolism reprogramming.
  • Investigation of metabolic pathways influenced by selective autophagy in tumor cells.

Main Results:

  • Selective autophagy pathways are activated by apoptosis-inducing cancer therapies.
  • These pathways reprogram cellular metabolism to cope with therapeutic stress.
  • Targeting these metabolic alterations holds potential for improving cancer treatment outcomes.

Conclusions:

  • Combining current cancer therapies with treatments targeting metabolic processes of selective autophagy can improve efficacy.
  • Exploiting or disrupting metabolic reprogramming induced by selective autophagy is a promising strategy for cancer treatment.
  • Understanding the interplay between selective autophagy and metabolism is key to augmenting cancer therapies.

More Related Videos

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy09:59

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy

Published on: May 3, 2013

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase09:51

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase

Published on: June 30, 2023

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...